Company Filing History:
Years Active: 2024
Title: Yihong Guan: Innovator in Cancer Treatment
Introduction
Yihong Guan is a notable inventor based in Cleveland, OH, who has made significant contributions to the field of cancer treatment. His innovative work focuses on the modulation of TET2, a critical factor in cancer therapy.
Latest Patents
Yihong Guan holds a patent for "Antitumor TET2 modulating compounds." This patent describes a method of treating cancer by administering a therapeutically effective amount of a TET2 activating compound or its pharmaceutically acceptable salt to a subject in need of treatment. The TET2 activating compounds identified in his research are α-ketoglutarate derivatives. Additionally, the patent outlines a method for treating or preventing cancer that includes analyzing a biological sample to determine if cells exhibit a TET2 mutation, alongside administering a TET2 activator.
Career Highlights
Yihong Guan is affiliated with the Cleveland Clinic Foundation, where he continues to advance his research in cancer treatment. His work has the potential to impact the lives of many patients suffering from cancer.
Collaborations
Some of his notable coworkers include Jaroslaw Maciejewski and Babal Kant Jha, who contribute to the collaborative efforts in research and development at the Cleveland Clinic Foundation.
Conclusion
Yihong Guan's innovative approach to cancer treatment through TET2 modulation exemplifies the importance of research in developing effective therapies. His contributions are paving the way for advancements in oncology.